Accordingly, dysregulation of GSK3β activity in the brain is involved in many neurological diseases and psychiatric disorders, such as Alzheimer’s disease, schizophrenia and bipolar disorder [2], [8]. The gene discussed is GSK3B; the disease is early-onset autosomal dominant Alzheimer disease.